The Latest News and Updates in Breast Cancer

There have been several updates in the field of breast cancer over the last several weeks. Here, CURE® looks back at some of the latest news and updates affecting patients with the disease.

• This report looks at how the breast cancer patient advocacy movement that started in the 1950s has pulled the disease out of the shadows, bringing patients’ options to light.
• A group extends a hand to those affected by breast or reproductive cancers, especially younger previvors, patients and caregivers.
• Data from a randomized phase 3 clinical trial recently published in JAMA Oncology show that a platinum-based chemotherapy combination may provide patients with operable triple-negative breast cancer (TNBC) an effective alternative adjuvant treatment option than what is currently in use.
• The Food and Drug Administration (FDA) recently issued a warning to patients, health care providers and trial investigators that the IMpassion131 trial — which evaluated the efficacy and safety of the immunotherapy Tecentriq (atezolizumab) in combination with the chemotherapy paclitaxel in patients with PD-L1-positive metastatic triple-negative breast cancer (mTNBC) — failed to effectively treat the disease.
• Treatments like kinase inhibitors are changing the options patient may have for when their breast cancer spreads to the brain.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.